Treatment Options for Pelvic Venous Disorders
At a Glance
Pelvic venous disorder treatment depends on whether pelvic veins have backward blood flow, a blockage, or both. Embolization is commonly used for backward flow, stenting for a symptomatic blockage, and conservative care may suit milder symptoms; the order is chosen for each patient.
Once a diagnosis of Pelvic Venous Disorder (PeVD) is confirmed, your treatment plan should be tailored to the specific biological mechanism causing your pain: reflux (leaky valves) or obstruction (a blockage). Because these mechanisms often coexist, the sequence in which they are treated is highly individualized.
Treatment Sequence and Shared Decision-Making
A core principle in modern pelvic venous care is to treat the “plumbing” thoughtfully based on your specific anatomy, symptoms, and collateral drainage.
- Reflux-Predominant: If your primary issue is blood flowing backward in the ovarian or pelvic veins without a major blockage, the standard treatment is often embolization [1][2].
- Obstruction-Predominant: If a major vein is significantly squeezed (as in symptomatic May-Thurner or Nutcracker syndromes), intervention may involve a stent to open that blockage [3].
Crucial Nuance: If you have both a blockage and reflux, treatment order is strictly individualized based on the vessels involved and the clinical significance of the obstruction. While treating a severe outflow blockage first is common in some practices to ensure blood has a proper drainage route, this is not a universal rule [1][4]. Ask your doctor why a specific sequence is recommended in your case.
It is also important to discuss your reproductive goals. If you plan to become pregnant in the future, you must discuss how a stent or embolization coils could be affected by pregnancy, and how any required blood-thinning medications would be managed.
Endovascular Embolization (For Reflux)
This is a minimally invasive procedure where a doctor uses a thin tube (catheter) to reach the faulty veins and block them off.
- How it Works: Doctors use tiny metal coils, plugs, or liquid sclerosing agents to close the “leaky” veins [5][6]. This forces blood to redirect into healthy, functioning veins.
- Success Rates: Technical success (successfully closing the targeted vein) is very high, often reaching 98–100% in studies [5]. However, technical occlusion is not the same as durable clinical symptom relief. While many patients experience a significant drop in pain, outcomes vary by patient selection, and recurrence is possible [7].
- What to Expect (Risks):
- Post-Embolization Syndrome (PES): A substantial number of patients experience a temporary flare-up of pelvic pain and a low-grade fever in the 7–14 days after the procedure as part of the expected inflammatory response [8][9].
- Thrombosis: Some degree of pelvic vein clotting can occur, though it is usually asymptomatic [8][10].
- Other Risks: Include access-site bleeding, infection, contrast or radiation risks, and rare events like non-target embolization or coil migration, where a coil moves to the lungs or heart [5][7].
Venous Stenting (For Obstruction)
When a vein is severely compressed and clinically symptomatic, a stent—a tiny mesh tube—can be used to hold the vein open [3][11].
- Outcomes: For appropriately selected patients with significant May-Thurner syndrome, stenting can provide relief [11]. However, compression alone without symptoms does not warrant a stent.
- Risks: Stents carry risks of “in-stent thrombosis” (the stent itself becoming blocked) or “in-stent restenosis” (narrowing over time). Migration is a rare but serious risk [12][13]. Some patients experience temporary back or “radicular” pain immediately after a stent is placed [14].
- Crucial Medication Plan: If you receive a stent, you will likely be prescribed antiplatelet or anticoagulant medications (blood thinners) for a clinician-determined period. You must obtain and strictly follow this medication plan and seek advice before stopping therapy.
Conservative and Medical Options
Not every patient requires a procedure. For those with milder symptoms or those who wish to avoid surgery, several non-invasive options exist, though evidence is limited:
- Compression Shorts: A small prospective study of Class II pelvic compression shorts found significant positive effects for many users after 14 days, offering a low-risk conservative option [15].
- Venoactive Drugs: Medications like micronized purified flavonoid fraction (MPFF), often sold under the brand name Daflon, have preliminary evidence for improving symptoms, though they are not universally approved or established in all regions [16][17].
- Hormonal Therapy: Treatments that suppress ovarian function (like certain birth control options) are sometimes used because estrogen affects veins. However, evidence is limited, side effects can occur, and hormonal options can carry their own risk of blood clots. An individualized discussion is essential [18][19].
Surgical Alternatives
In the past, major surgeries like gonadal vein resection were more common [6]. Today, they are less common due to endovascular options. Importantly, a hysterectomy (removing the uterus) does not correct pelvic venous reflux or obstruction and should only be considered if there is a separate, confirmed uterine indication for the surgery [19][20].
Common questions in this guide
What treatment is usually used for pelvic congestion syndrome?
How does pelvic vein embolization work, and what happens afterward?
When is a venous stent used for pelvic venous disorder?
What if I have both pelvic vein blockage and backward flow?
Can conservative treatments help pelvic congestion syndrome?
Is a hysterectomy a treatment for pelvic venous disorder?
How do pregnancy plans affect pelvic venous disorder treatment?
Get notified when new evidence is published on pelvic congestion syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (20)
- 1
Treatment Algorithm for Patients with Nonthrombotic Iliac Vein Lesions and Venous-Origin Chronic Pelvic Pain.
Gavrilov SG, Alenichev AV, Vasiliev AV, et al.
Journal of vascular and interventional radiology : JVIR 2026; (37(10)):108962 doi:10.1016/j.jvir.2026.108962.
PMID: 42468837 - 2
A keep-it-simple embolisation approach to treat pelvic congestion syndrome without compromising clinical effectiveness.
Liang E, Wong WYT, Parvez R, et al.
Journal of medical imaging and radiation oncology 2025; (69(1)):91-99 doi:10.1111/1754-9485.13795.
PMID: 39428119 - 3
Review of the literature supporting international clinical practice guidelines on iliac venous stenting and their applicability to Australia and New Zealand practice.
Villalba LM, Bayat I, Dubenec S, et al.
Journal of vascular surgery. Venous and lymphatic disorders 2024; (12(5)):101843 doi:10.1016/j.jvsv.2024.101843.
PMID: 38316289 - 4
Comparative Study Between Isolated Iliac Vein Stenting Versus Concomitant Iliac Vein Stenting with Pelvic Vein Embolization in Patients with Pelvic Venous Insufficiency Secondary to Nonthrombotic Iliac Vein Lesions.
Mokhtar HHM, Salem AM, Zaki MM, Emara MH
Annals of vascular surgery 2026; (133()):860-869 doi:10.1016/j.avsg.2026.08.039.
PMID: 42697323 - 5
Pelvic vein embolization using different embolic agents for the treatment of pelvic venous insufficiency: A systematic review and meta-analysis.
Strobl F, Böhm AK, Mertens L, et al.
Journal of vascular surgery. Venous and lymphatic disorders 2026; (14(6)):102599 doi:10.1016/j.jvsv.2026.102599.
PMID: 42571790 - 6
Surgical and endovascular treatment of pelvic venous disorder: Results of a multicentre retrospective cohort study.
Gavrilov SG, Sazhin AV, Akhmetzianov R, et al.
Journal of vascular surgery. Venous and lymphatic disorders 2023; (11(5)):1045-1054 doi:10.1016/j.jvsv.2023.04.009.
PMID: 37150252 - 7
Pelvic Venous Disorders in Women due to Pelvic Varices: Treatment by Embolization: Experience in 520 Patients.
De Gregorio MA, Guirola JA, Alvarez-Arranz E, et al.
Journal of vascular and interventional radiology : JVIR 2020; (31(10)):1560-1569 doi:10.1016/j.jvir.2020.06.017.
PMID: 32855049 - 8
Complications and Adverse Events of Gonadal Vein Embolization with Coils.
Gavrilov SG, Mishakina NY, Efremova OI, Kirsanov KV
Journal of personalized medicine 2022; (12(11)) doi:10.3390/jpm12111933.
PMID: 36422109 - 9
The Effect of Venoactive Drug Therapy on the Development and Severity of Post-Embolization Syndrome in Endovascular Interventions on the Gonadal Veins.
Gavrilov SG, Krasavin GV, Mishakina NY, et al.
Journal of personalized medicine 2021; (11(6)) doi:10.3390/jpm11060521.
PMID: 34200127 - 10
Venous Thromboembolism After Interventions on the Ovarian Veins in Patients With Pelvic Venous Disorder.
Gavrilov SG, Mishakina NY, Grishenkova AS
Annals of vascular surgery 2023; (91()):191-200 doi:10.1016/j.avsg.2022.11.016.
PMID: 36464150 - 11
Randomized double-blinded study comparing medical treatment versus iliac vein stenting in chronic venous disease.
Rossi FH, Kambara AM, Izukawa NM, et al.
Journal of vascular surgery. Venous and lymphatic disorders 2018; (6(2)):183-191 doi:10.1016/j.jvsv.2017.11.003.
PMID: 29292114 - 12
In-stent restenosis and stent compression following stenting for chronic iliofemoral venous obstruction.
Jayaraj A, Fuller R, Raju S, Stafford J
Journal of vascular surgery. Venous and lymphatic disorders 2022; (10(1)):42-51 doi:10.1016/j.jvsv.2021.06.009.
PMID: 34174500 - 13
A Systematic Review on the Incidence of Stent Migration in the Treatment of Acute and Chronic Iliofemoral Disease Using Dedicated Venous Stents.
Badesha AS, Siddiqui MM, Bains BRS, et al.
Annals of vascular surgery 2022; (83()):328-348 doi:10.1016/j.avsg.2021.12.084.
PMID: 35051587 - 14
A practice audit of short-term outcomes of Wallstents versus Venovo stents for the treatment of nonthrombotic iliac vein outflow stenoses.
Sulakvelidze L, Lakhanpal G, Lakhanpal S, et al.
Journal of vascular surgery. Venous and lymphatic disorders 2023; (11(2)):357-364 doi:10.1016/j.jvsv.2022.08.007.
PMID: 36182087 - 15
Compression treatment of pelvic congestion syndrome.
Gavrilov SG, Karalkin AV, Turischeva OO
Phlebology 2018; (33(6)):418-424 doi:10.1177/0268355517717424.
PMID: 28639874 - 16
Clinical Efficacy of Conservative Treatment with Micronized Purified Flavonoid Fraction in Female Patients with Pelvic Congestion Syndrome.
Akhmetzianov RV, Bredikhin RA
Pain and therapy 2021; (10(2)):1567-1578 doi:10.1007/s40122-021-00312-6.
PMID: 34537951 - 17
Venoactive drugs for venous origin chronic pelvic pain in women: A systematic review.
Gloviczki ML, Demetres MR, Salazar G, Khilnani NM
Phlebology 2026; (41(7)):579-599 doi:10.1177/02683555251411027.
PMID: 41432346 - 18
Clinical outcome after treatment of pelvic congestion syndrome: sense and nonsense.
Meissner MH, Gibson K
Phlebology 2015; (30(1 Suppl)):73-80 doi:10.1177/0268355514568067.
PMID: 25729071 - 19
Conservative treatment of pelvic congestion syndrome: indications and opportunities.
Gavrilov SG, Turischeva OO
Current medical research and opinion 2017; (33(6)):1099-1103 doi:10.1080/03007995.2017.1302414.
PMID: 28277860 - 20
Endovascular reintervention versus conservative medical therapy for persistent or recurrent venous-origin chronic pelvic pain after primary ovarian vein embolization.
Xue S, Li F, Lu T, et al.
Journal of vascular surgery. Venous and lymphatic disorders 2026; (14(6)):102571 doi:10.1016/j.jvsv.2026.102571.
PMID: 42379296
This page is for informational purposes only and does not constitute medical advice about pelvic venous disorders. Discuss your anatomy, reproductive goals, medication plan, and procedure risks with your treating clinician.